A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients

被引:0
|
作者
Xiaochun Yin
Feng Zhang
Huiwen Guo
Chunyan Peng
Wei Zhang
Jiangqiang Xiao
Yi Wang
Xiaoping Zou
Ming Zhang
Yuzheng Zhuge
机构
[1] Department of Gastroenterology,
[2] Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University,undefined
[3] Department of Gastroenterology,undefined
[4] Nanjing Drum Tower Hospital,undefined
[5] The Affiliated Hospital of Nanjing University Medical School,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Background and Aim: Hepatic encephalopathy (HE) is a serious complication of decompensated liver cirrhosis, affecting the prognosis of patients underwent transjugular intrahepatic portosystemic shunts (TIPS). We aim to create a nomogram to predict hepatic encephalopathy- free survivals (HEFS) after TIPS in cirrhotic patients and select appropriate candidates for TIPS. Methods: Cirrhotic patients underwent TIPS from 2015 to 2018 in our department were included. Multivariable Cox regression was conducted to estimate the predictors of overt HE (OHE) after TIPS within one year. A nomogram based on the Cox proportional hazard model using data from a retrospective training cohort (70% of the patients) was developed. Then the prediction model was validated in the remaining 30% patients by Harrell’s C-indexes, ROC curves and calibration plots. Results: Of 373 patients, 117 developed postoperative OHE (31.4%). The training and validation groups comprised 83 (31.4%) and 34 (31.2%) patients, respectively. The cumulative survival rates of patients with HE at 1, 2 and 3 years were 90%, 83% and 76%, respectively. The nomogram included the following variables: age, Child-Turcotte-Pugh class (CTP class), diabetes mellitus (DM), serum creatinine and serum sodium (C-index = 0.772). The C-index for HEFS prediction was 0.773 for the validation cohort. The ROC for predicting HEFS was 0.809 and 0.783, respectively. Conclusions: We created a nomogram of predicting postoperative HEFS in cirrhotic patients received TIPS. This nomogram could be an important tool of HE risk prediction before TIPS to guide the therapeutic strategy in cirrhotic patients.
引用
收藏
相关论文
共 50 条
  • [21] SARCOPENIA REPRESENTS A RISK FACTOR FOR THE DEVELOPMENT OF HEPATIC ENCEPHALOPATHY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT
    Nardelli, S.
    Lattanzi, B.
    Gioia, S.
    Greco, F.
    Torrisi, S.
    Merli, M.
    Riggio, O.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 : E115 - E116
  • [22] Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter
    Xiaoze Wang
    Xuefeng Luo
    Li Yang
    [J]. Digestive Diseases and Sciences, 2021, 66 : 4568 - 4569
  • [23] Socioeconomic Status Is Associated with the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation
    Helzberg, James H.
    Dai, Rui
    Muir, Andrew J.
    Wilder, Julius
    Lee, Tzu-Hao
    Martin, Jonathan G.
    Kim, Charles Y.
    Ronald, James
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 32 (07) : 950 - +
  • [24] Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience
    Masson, S.
    Mardini, H. A.
    Rose, J. D.
    Record, C. O.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2008, 101 (06) : 493 - 501
  • [25] Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Still a Major Problem
    Riggio, Oliviero
    Angeloni, Stefania
    Ridola, Lorenzo
    [J]. HEPATOLOGY, 2010, 51 (06) : 2237 - 2238
  • [26] Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis
    Tong, Huan
    Gan, Can
    Wei, Bo
    Wang, Zhi Dong
    Li, Xiao Dan
    Qian, Shuai Jie
    Huan, Hui
    Zhang, Lin Hao
    Yang, Zhu
    Chen, Yi Long
    Gu, Yong Hong
    Chen, Liu Xiang
    Yang, Yu Hang
    Wu, Hao
    Tang, Cheng Wei
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (01) : 31 - 40
  • [27] Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension
    Yao, Jiannan
    Zuo, Li
    An, Guangyu
    Yue, Zhendong
    Zhao, Hongwei
    Wang, Lei
    Liu, Fuquan
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2015, 24 (03) : 301 - 307
  • [28] Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement
    Thornburg, Bartley
    [J]. SEMINARS IN INTERVENTIONAL RADIOLOGY, 2023, 40 (03) : 262 - 268
  • [29] RISK FACTORS FOR OVERT HEPATIC ENCEPHALOPATHY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT CREATION IN LIVER CIRRHOSIS PATIENTS
    Tong, Huan
    Wei, Bo
    Wu, Hao
    Tang, Chengwei
    [J]. HEPATOLOGY, 2019, 70 : 255A - 255A
  • [30] Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt
    Chuhan Wang
    Yue Teng
    Jin Gao
    Zichen Zhang
    Yonggang Li
    [J]. Abdominal Radiology, 2023, 48 : 1454 - 1467